Picture of EvoNext Holdings SA logo

EVE EvoNext Holdings SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Evolva gains exclusive license from CDC to develop and commercialise nootkatone

April 5 (Reuters) - Evolva Holding SA  EVE.S : 
    * Gains exclusive license from CDC to develop and 
commercialise nootkatone globally for pest control 
    * Also signs broader nootkatone collaboration agreement with 
CDC 
 
Source text for Eikon:  ID:nTENpba7ga  
Further company coverage:  EVE.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on EvoNext Holdings SA

See all news